Highlights and Quick Summary
- Annual ROA for 2022 was -17.3% (a 3.97% increase from previous year)
- Annual ROA for 2021 was -16.64% (a -63.22% decrease from previous year)
- Annual ROA for 2020 was -45.24% (a -99.01% decrease from previous year)
- Twelve month ROA ending June 30, 2023 was -21.86% (a 10.91% increase compared to previous quarter)
- Twelve month trailing ROA increased by 44.67% year-over-year
Trailing ROA for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -21.86% | -19.71% | -17.3% | -15.11% |
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROA of Design Therapeutics, Inc.
Most recent ROAof DSGN including historical data for past 10 years.Interactive Chart of ROA of Design Therapeutics, Inc.
Design Therapeutics, Inc. ROA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -17.3% |
| 2021 | – | – | – | – | -16.64% |
| 2020 | – | – | – | – | -45.24% |
| 2019 | – | – | – | – | -4548.89% |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology